Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)
Clinical trial NCT03942120 · COMPLETED
Trial details
- NCT number
- NCT03942120
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-04-08
- Primary completion
- 2022-01-14
- Enrollment
- 685
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.